$NVTS
Navitas Semiconductor Corp

2021 Q1 Form 10-Q Financial Statement

#000119312521170793 Filed on May 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4
Revenue $5.317M $4.653M
YoY Change 350.59%
Cost Of Revenue $2.959M $3.107M
YoY Change 205.05%
Gross Profit $2.358M $1.546M
YoY Change 1022.86%
Gross Profit Margin 44.35% 33.23%
Selling, General & Admin $5.369M $3.845M
YoY Change 257.93%
% of Gross Profit 227.69% 248.71%
Research & Development $4.254M $4.910M
YoY Change 74.34%
% of Gross Profit 180.41% 317.59%
Depreciation & Amortization $80.00K $235.0K
YoY Change -11.11%
% of Gross Profit 3.39% 15.2%
Operating Expenses $9.623M $8.752M
YoY Change 144.24%
Operating Profit -$7.265M -$7.206M
YoY Change 94.77%
Interest Expense -$61.00K -$64.00K
YoY Change 22.0%
% of Operating Profit
Other Income/Expense, Net -$61.00K
YoY Change
Pretax Income -$7.326M -$7.270M
YoY Change 93.3%
Income Tax $19.00K -$1.000K
% Of Pretax Income
Net Earnings -$7.345M -$7.269M
YoY Change 93.8%
Net Earnings / Revenue -138.14% -156.22%
Basic Earnings Per Share -$0.37
Diluted Earnings Per Share -$0.37 -$61.74K
COMMON SHARES
Basic Shares Outstanding 19.74M shares
Diluted Shares Outstanding 19.74M shares

Balance Sheet

Concept 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.29M $1.896M
YoY Change
Cash & Equivalents $1.554M $38.87M
Short-Term Investments
Other Short-Term Assets $321.0K $113.9K
YoY Change
Inventory $5.059M $3.404M
Prepaid Expenses $185.3K $113.9K
Receivables $3.793M $4.152M
Other Receivables $0.00
Total Short-Term Assets $1.739M $46.95M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $943.0K $722.0K
YoY Change
Goodwill
YoY Change
Intangibles $515.0K
YoY Change
Long-Term Investments $253.0M
YoY Change
Other Assets $97.00K $102.0K
YoY Change
Total Long-Term Assets $253.1M $1.560M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.739M $46.95M
Total Long-Term Assets $253.1M $1.560M
Total Assets $254.8M $48.51M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.183M
YoY Change
Accrued Expenses $124.9K $90.47K
YoY Change
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.600M $1.000M
YoY Change
Total Short-Term Liabilities $125.1K $6.366M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $4.375M $4.971M
YoY Change
Other Long-Term Liabilities $78.00K $88.00K
YoY Change
Total Long-Term Liabilities $4.453M $5.059M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $125.1K $6.366M
Total Long-Term Liabilities $4.453M $5.059M
Total Liabilities $26.93M $11.43M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.256M -$75.98M
YoY Change
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$77.71M -$72.42M
YoY Change
Total Liabilities & Shareholders Equity $254.8M $48.51M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income -$7.345M -$7.269M
YoY Change 93.8%
Depreciation, Depletion And Amortization $80.00K $235.0K
YoY Change -11.11%
Cash From Operating Activities -$5.812M -$7.840M
YoY Change 11.98%
INVESTING ACTIVITIES
Capital Expenditures $312.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.000K $8.000K
YoY Change
Cash From Investing Activities -$990.0K $8.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$222.0K
YoY Change -104.02%
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities $222.0K -401.0K
YoY Change -95.48%
NET CHANGE
Cash From Operating Activities -$5.812M -7.840M
Cash From Investing Activities -$990.0K 8.000K
Cash From Financing Activities $222.0K -401.0K
Net Change In Cash -$6.577M -8.233M
YoY Change 2248.93%
FREE CASH FLOW
Cash From Operating Activities -$5.812M -$7.840M
Capital Expenditures $312.0K $0.00
Free Cash Flow -$6.124M -$7.840M
YoY Change 18.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Trading Symbol
TradingSymbol
LOKB
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001821769
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2021Q1 us-gaap Cash
Cash
1554154
CY2020Q4 us-gaap Cash
Cash
1896170
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
185254
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
113867
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1739408
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2010037
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
253055709
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
253018241
CY2021Q1 us-gaap Assets
Assets
254795117
CY2020Q4 us-gaap Assets
Assets
255028278
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
124902
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90471
CY2021Q1 lokb Accrued Offering Costs Current
AccruedOfferingCostsCurrent
171
CY2020Q4 lokb Accrued Offering Costs Current
AccruedOfferingCostsCurrent
27981
CY2021Q1 lokb Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8067500
CY2020Q4 lokb Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8067500
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18733001
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
20436001
CY2021Q1 us-gaap Liabilities
Liabilities
26925574
CY2020Q4 us-gaap Liabilities
Liabilities
28621953
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
222869540
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
221406320
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
254795117
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
255028278
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
280158
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-280158
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1703000
CY2021Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
2905
CY2021Q1 lokb Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
37468
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-314206
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7255150
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
125073
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
118452
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8718352
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2256081
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3719296
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1463217
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1463215
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1703000
CY2021Q1 lokb Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
37468
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
71387
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
34434
CY2021Q1 lokb Change In Value Of Classa Common Shares Subject To Possible Redemption
ChangeInValueOfClassaCommonSharesSubjectToPossibleRedemption
1463217
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
27810
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27810
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-342016
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1896170
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1554154
CY2021Q1 lokb Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
-27810
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-08-12
CY2021Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
7000000
CY2021Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
253000000
CY2021Q1 lokb Restricted Investment Per Share Value
RestrictedInvestmentPerShareValue
10.00
CY2021Q1 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2021Q1 lokb Percentage Of The Public Shares Eligible To Be Transferred Without Any Restriction
PercentageOfThePublicSharesEligibleToBeTransferredWithoutAnyRestriction
0.15
CY2021Q1 lokb Percentage Of The Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfThePublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1.00
CY2021Q1 lokb Period Within Which Business Combination Shall Be Completed From The Date Of Closure Of Initial Public Offer
PeriodWithinWhichBusinessCombinationShallBeCompletedFromTheDateOfClosureOfInitialPublicOffer
P24D
CY2021Q1 lokb Number Of Business Days Within Which Public Shares Shall Be Redeemed
NumberOfBusinessDaysWithinWhichPublicSharesShallBeRedeemed
P10D
CY2021Q1 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2021Q1 lokb Minimum Per Share Amount To Be Maintained In The Trust Account
MinimumPerShareAmountToBeMaintainedInTheTrustAccount
10.00
CY2021Q1 lokb Net Working Capital
NetWorkingCapital
1614335
CY2021Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
50000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</div></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
685-2865
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance <div style="letter-spacing: 0px; top: 0px;;display:inline;">Corporation</div> limit of $250,000. As of March&#160;31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q1 lokb Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
0.1
CY2021Q1 lokb Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2021Q1 lokb Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
8000000
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Live Oak Acquisition Corp II
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
CY2021Q1 dei Entity File Number
EntityFileNumber
001-39755
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2560226
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
40 S. Main Street, #2550
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Memphis
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
38103
CY2021Q1 dei City Area Code
CityAreaCode
901

Files In Submission

Name View Source Status
0001193125-21-170793-index-headers.html Edgar Link pending
0001193125-21-170793-index.html Edgar Link pending
0001193125-21-170793.txt Edgar Link pending
0001193125-21-170793-xbrl.zip Edgar Link pending
d180215d10q.htm Edgar Link pending
d180215dex311.htm Edgar Link pending
d180215dex312.htm Edgar Link pending
d180215dex321.htm Edgar Link pending
d180215dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lokb-20210331.xml Edgar Link completed
lokb-20210331.xsd Edgar Link pending
lokb-20210331_cal.xml Edgar Link unprocessable
lokb-20210331_def.xml Edgar Link unprocessable
lokb-20210331_lab.xml Edgar Link unprocessable
lokb-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending